TY - JOUR
T1 - Postoperative Opioid Consumption in Thoracic Surgery Patients
T2 - How Much Is Actually Used?
AU - Holst, Kimberly A.
AU - Thiels, Cornelius A.
AU - Ubl, Daniel S.
AU - Blackmon, Shanda H.
AU - Cassivi, Stephen D.
AU - Nichols, Francis C.
AU - Shen, K. Robert
AU - Wigle, Dennis A.
AU - Thomas, Mathew
AU - Makey, Ian A.
AU - Beamer, Staci E.
AU - Jaroszewski, Dawn E.
AU - Allen, Mark S.
AU - Habermann, Elizabeth B.
N1 - Publisher Copyright:
© 2020 The Society of Thoracic Surgeons
PY - 2020/4
Y1 - 2020/4
N2 - Background: The objective of this initiative was to perform a prospective, multicenter survey of patients after lung resection to assess the amount of opioid medication consumed and the disposition of unused opioids to inform the development of evidence-based prescribing guidelines. Methods: Adults undergoing lung resection with either minimally invasive surgery (MIS; n = 108) or thoracotomy (n = 45) were identified prospectively from 3 academic centers (from March 2017 to January 2018) to complete a 28-question telephone survey 21 to 35 days after discharge. Discharge opioids were converted into morphine milligram equivalents (MME) and were compared across patient and surgical details. Results: Of the 153 patients who completed the survey, 89.5% (137) received opioids at discharge with a median prescription of 320 MME (interquartile range [IQR], 225, 450 MME) after MIS and 450 MME (IQR, 300, 600 MME) after thoracotomy (P = .001). Median opioid consumption varied by surgical approach: 90 MME (IQR, 0, 262.5) after MIS and 300 MME (IQR, 50, 382.5 MME) after thoracotomy (P < .001). The majority of patients (73.7%; 101) had residual opioid medication at the time of the survey, and patients after MIS had a relative increase in amount of remaining opioid medication: 58.3% vs 33.3% (P = .05) of the original prescription. Only 5.9% of patients with opioids remaining had properly disposed of them. Conclusions: Although patients undergoing MIS lung resection used significantly less opioid medication over a shorter duration of time than did patients after thoracotomy, they had relatively more excess opioid prescription. Evidence-based, procedure-specific guidelines with tailored pain regimens should be developed and implemented to reduce the amount of postoperative opioid medication remaining in the community.
AB - Background: The objective of this initiative was to perform a prospective, multicenter survey of patients after lung resection to assess the amount of opioid medication consumed and the disposition of unused opioids to inform the development of evidence-based prescribing guidelines. Methods: Adults undergoing lung resection with either minimally invasive surgery (MIS; n = 108) or thoracotomy (n = 45) were identified prospectively from 3 academic centers (from March 2017 to January 2018) to complete a 28-question telephone survey 21 to 35 days after discharge. Discharge opioids were converted into morphine milligram equivalents (MME) and were compared across patient and surgical details. Results: Of the 153 patients who completed the survey, 89.5% (137) received opioids at discharge with a median prescription of 320 MME (interquartile range [IQR], 225, 450 MME) after MIS and 450 MME (IQR, 300, 600 MME) after thoracotomy (P = .001). Median opioid consumption varied by surgical approach: 90 MME (IQR, 0, 262.5) after MIS and 300 MME (IQR, 50, 382.5 MME) after thoracotomy (P < .001). The majority of patients (73.7%; 101) had residual opioid medication at the time of the survey, and patients after MIS had a relative increase in amount of remaining opioid medication: 58.3% vs 33.3% (P = .05) of the original prescription. Only 5.9% of patients with opioids remaining had properly disposed of them. Conclusions: Although patients undergoing MIS lung resection used significantly less opioid medication over a shorter duration of time than did patients after thoracotomy, they had relatively more excess opioid prescription. Evidence-based, procedure-specific guidelines with tailored pain regimens should be developed and implemented to reduce the amount of postoperative opioid medication remaining in the community.
UR - http://www.scopus.com/inward/record.url?scp=85081702759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081702759&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2019.08.115
DO - 10.1016/j.athoracsur.2019.08.115
M3 - Article
C2 - 31689406
AN - SCOPUS:85081702759
SN - 0003-4975
VL - 109
SP - 1033
EP - 1039
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 4
ER -